Katie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.
Key topics include:
- What is Ad Promo?
- Chevron decision's influence on FDA/FTC
- Should administrative agencies cite letters?
- Can the FDA establish rules after someone challenges them?
- Uncertainty of Compliance White Space
- Is regulatory medical advice now just seen as a risk?
Support the show
